Literature DB >> 9405632

Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides.

Y Tagaya1, G Kurys, T A Thies, J M Losi, N Azimi, J A Hanover, R N Bamford, T A Waldmann.   

Abstract

Two isoforms of human interleukin 15 (IL-15) exist. One isoform has a shorter putative signal peptide (21 amino acids) and its transcript shows a tissue distribution pattern that is distinct from that of the alternative IL-15 isoform with a 48-aa signal peptide. The 21-aa signal isoform is preferentially expressed in tissues such as testis and thymus. Experiments using different combinations of signal peptides and mature proteins (IL-2, IL-15, and green fluorescent protein) showed that the short signal peptide regulates the fate of the mature protein by controlling the intracellular trafficking to nonendoplasmic reticulum sites, whereas the long signal peptide both regulates the rate of protein translation and functions as a secretory signal peptide. As a consequence, the IL-15 associated with the short signal peptide is not secreted, but rather is stored intracellularly, appearing in the nucleus and cytoplasmic components. Such production of an intracellular lymphokine is not typical of other soluble interleukin systems, suggesting a biological function for IL-15 as an intracellular molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405632      PMCID: PMC25016          DOI: 10.1073/pnas.94.26.14444

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon.

Authors:  P Acland; M Dixon; G Peters; C Dickson
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

2.  Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation.

Authors:  R N Bamford; A P Battiata; J D Burton; H Sharma; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

Review 3.  IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels.

Authors:  Y Tagaya; R N Bamford; A P DeFilippis; T A Waldmann
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

4.  Chromosomal assignment and genomic structure of Il15.

Authors:  D M Anderson; L Johnson; M B Glaccum; N G Copeland; D J Gilbert; N A Jenkins; V Valentine; M N Kirstein; D N Shapiro; S W Morris
Journal:  Genomics       Date:  1995-02-10       Impact factor: 5.736

5.  A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

Authors:  J D Burton; R N Bamford; C Peters; A J Grant; G Kurys; C K Goldman; J Brennan; E Roessler; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

Authors:  R N Bamford; A J Grant; J D Burton; C Peters; G Kurys; C K Goldman; J Brennan; E Roessler; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

Review 8.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

9.  Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor.

Authors:  J G Giri; S Kumaki; M Ahdieh; D J Friend; A Loomis; K Shanebeck; R DuBose; D Cosman; L S Park; D M Anderson
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

10.  Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.

Authors:  J G Giri; M Ahdieh; J Eisenman; K Shanebeck; K Grabstein; S Kumaki; A Namen; L S Park; D Cosman; D Anderson
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

View more
  52 in total

1.  Production and distribution of interleukin 15 and its receptors (IL-15Ralpha and IL-R2beta) in the implant interface tissues obtained during revision of failed total joint replacement.

Authors:  S Saeed; P A Revell
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

2.  The efficiency of protein compartmentalization into the secretory pathway.

Authors:  Corinna G Levine; Devarati Mitra; Ajay Sharma; Carolyn L Smith; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2004-10-20       Impact factor: 4.138

3.  Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine.

Authors:  Cary Hsu; Marybeth S Hughes; Zhili Zheng; Regina B Bray; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

4.  Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen.

Authors:  Wei Zhang; Sheng-Fu Dong; Shu-Hui Sun; Yuan Wang; Guang-Di Li; Di Qu
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

5.  Interleukin-15 increases neutrophil adhesion onto human respiratory epithelial A549 cells and attracts neutrophils in vivo.

Authors:  M Pelletier; D Girard
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

6.  Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs.

Authors:  B P Haines; R B Voyle; P D Rathjen
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

7.  Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression.

Authors:  Stephanie K Watkins; Bing Li; Katharine S Richardson; Kimberly Head; Nejat K Egilmez; Qun Zeng; Jill Suttles; Robert D Stout
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

8.  Secretion and biological activity of short signal peptide IL-15 is chaperoned by IL-15 receptor alpha in vivo.

Authors:  Cristina Bergamaschi; Rashmi Jalah; Viraj Kulkarni; Margherita Rosati; Gen-Mu Zhang; Candido Alicea; Andrei S Zolotukhin; Barbara K Felber; George N Pavlakis
Journal:  J Immunol       Date:  2009-09-01       Impact factor: 5.422

9.  Cerebral microvascular IL15 is a novel mediator of TNF action.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Reas S Khan; Abba J Kastin
Journal:  J Neurochem       Date:  2009-08-31       Impact factor: 5.372

Review 10.  The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases.

Authors:  Cem Gabay; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.